TearLab Corp  

(Public, NASDAQ:TEAR)   Watch this stock  
Find more results for Paul Lindstrom
+0.010 (1.14%)
Real-time:   9:44AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.81 - 0.84
52 week 0.58 - 3.03
Open 0.81
Vol / Avg. 8,767.00/243,772.00
Mkt cap 48.95M
P/E     -
Div/yield     -
EPS -0.96
Shares 56.76M
Beta 3.08
Inst. own 23%
Aug 3, 2016
Q2 2016 TearLab Corp Earnings Call - 4:30PM EDT - Add to calendar
Aug 3, 2016
Q2 2016 TearLab Corp Earnings Release - 4:00PM EDT - Add to calendar
May 4, 2016
Q1 2016 TearLab Corp Earnings Call
May 4, 2016
Q1 2016 TearLab Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -107.20% -132.09%
Operating margin -93.63% -125.25%
EBITD margin - -105.43%
Return on average assets -116.85% -111.92%
Return on average equity - -329.91%
Employees 118 -
CDP Score - -


Suite 200, 7360 Carroll Rd
United States - Map
+1-858-4556006 (Phone)
+1-858-8120540 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Officers and directors

Elias Vamvakas Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Jensen President, Chief Executive Officer, Chief Operating Officer, Director
Age: 43
Bio & Compensation  - Reuters
Wes Brazell Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Raymond Kong Vice President - Sales
Bio & Compensation  - Reuters
Venkiteshwar Manoj Vice President of Medical Affairs
Age: 37
Bio & Compensation  - Reuters
Paul Smith Vice President - International Markets
Age: 37
Bio & Compensation  - Reuters
Duane Morrison Vice President - Business Development
Age: 51
Bio & Compensation  - Reuters
Anthony E. Altig Independent Director
Age: 59
Bio & Compensation  - Reuters
Thomas N. Davidson Jr. Independent Director
Age: 55
Bio & Compensation  - Reuters
Adrienne L. Graves Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters